Can you take Mounjaro if you have no gallbladder?

Does missing a gallbladder change whether Mounjaro is safe to use?

The short answer is: not categorically, but the question is worth taking seriously. Mounjaro's Summary of Product Characteristics, published on the Electronic Medicines Compendium, does not list prior cholecystectomy as a reason to avoid tirzepatide. In that sense, having your gallbladder removed does not automatically rule out treatment in the UK.

What it does change is the context a prescriber works with. The gallbladder stores bile between meals; once it is removed, bile drains continuously from the liver into the small intestine rather than being released in coordinated bursts. Tirzepatide slows gastric emptying and alters the hormonal signalling around digestion. For most people who have had a cholecystectomy this does not cause a problem, but some individuals notice that changes to digestive timing can shift how their body handles fats. That is worth mentioning at consultation rather than assuming it is irrelevant.

Our prescribers at nume ask about surgical history, including gallbladder removal, as a routine part of the clinical review. It is one of several factors that shapes the overall picture rather than a binary pass or fail.

What does the gallbladder connection with GLP-1 medicines actually mean?

GLP-1 receptor agonists (the class that includes both semaglutide and tirzepatide) have a known association with gallbladder and biliary tract conditions. Cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) have been reported during clinical trials, and the NHS patient information for tirzepatide lists gallbladder problems among side effects to be aware of.

If you no longer have a gallbladder, gallstones forming inside the gallbladder itself are not possible. However, the bile ducts remain, and bile duct stones or inflammation of the biliary tract can still occur in people who have had a cholecystectomy. This is not common, and it should not be read as a reason to avoid treatment, but it is a reason to know the warning symptoms and to tell your prescriber about your history. Our dedicated page looking at whether you can have Mounjaro with no gallbladder covers how tirzepatide interacts with the biliary system in more detail, and you can also find a broader look at the topic on our Mounjaro and gallbladder page.

One practical checking habit worth building: before each new pen, spend thirty seconds reading your current medicines list against the Patient Information Leaflet. It takes under a minute and is the fastest way to catch anything you might have overlooked.

When should you seek medical help, and what counts as urgent?

For anyone taking Mounjaro, regardless of gallbladder status, certain symptoms need prompt medical attention. Severe stomach pain that does not settle and spreads towards the back, with or without vomiting, should be assessed urgently, this can indicate pancreatitis, a known but infrequent risk with GLP-1 medicines flagged in the MHRA's January 2026 Drug Safety Update. Do not wait to see if it passes.

Signs that could point to biliary tract problems include pain in the upper right abdomen, fever, yellowing of the skin or eyes (jaundice), or dark urine. Even without a gallbladder, these symptoms warrant a call to your GP or 111. You can also report any suspected side effect to the MHRA using the Yellow Card scheme, which actively monitors safety signals for newer medicines including Mounjaro.

If you are already on treatment and experience anything unexpected, our team is available seven days a week through priority aftercare. For a fuller picture of what to watch for on tirzepatide more broadly, the Mounjaro side effects page covers the full profile in detail.

How does this affect starting Mounjaro, what should you tell your prescriber?

Being open about gallbladder history is the most useful thing you can do before treatment begins. That means mentioning: when your cholecystectomy was performed, whether it was laparoscopic or open surgery, whether you had any complications afterwards (bile duct stones, post-cholecystectomy syndrome, ongoing digestive symptoms), and whether you are on any medicines that affect bile metabolism.

This information will not necessarily prevent approval, it helps the prescriber make an informed decision and, if treatment goes ahead, to set realistic expectations around digestive side effects during the early weeks. The GI effects of tirzepatide (nausea, looser stools, changes in digestion) can occasionally feel more pronounced in people whose digestive rhythm changed after cholecystectomy, and knowing this in advance lets you manage the adjustment period sensibly. If you are also noticing thinning hair during treatment, our page on whether hair lost on Mounjaro will grow back explains what the evidence currently shows.

If you are ready to have that conversation, speaking to our prescribers is straightforward. The consultation is free, and your answers are reviewed by a GPhC-registered Independent Prescriber (a named clinician, not automated software) the same day. For general information on what treatment involves, the Mounjaro overview is a good place to start, and our weight-loss treatments page covers how tirzepatide fits into the broader options available.